Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
JCV test stratifies PML risk in antibody-positive MS
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Multiple sclerosis: a comprehensive review for the physician assistant.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
The gut microbiome in multiple sclerosis.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
FDA approval of Isentress (raltegravir)
Proteomic analysis of the anti-inflammatory action of minocycline.

Pages